LUCYW · Innovative Eyewear Inc
$0.04
0.00 (-8.60%)
At close · Aug 14
Market Cap
$6.03M
Shares
8.61M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.66M
+62.6%
FY2025
Net Income
-$7.59M
+2.3%
FY2025
Gross Margin
21.32%
+8.2pp
FY2025
Diluted EPS
-$1.90
+63.4%
FY2025
Operating Cash Flow
-$7.28M
-7.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $3.41M | $2.66M | $1.64M | $1.15M | $659.79K | $690.67K | |
| $2.63M | $2.09M | $1.42M | $1.27M | $716.08K | $542.42K | |
| $777.54K | $567.45K | $215.19K | -$119.33K | -$56.29K | $148.25K | |
| — | 21.32% | 13.15% | -10.35% | -8.53% | 21.47% | |
| $526.79K | $725.39K | $819.39K | $662.18K | $524.69K | $86.26K | |
| $2.98M | $2.97M | $2.71M | $2.05M | $2.06M | $1.77M | |
| $5.63M | $5.23M | $4.47M | $3.89M | $2.8M | $1.39M | |
| — | $68.55K | $39.9K | $24.16K | $10.47K | $7179 | |
| — | $66.79K | $109.49K | $61.09K | $22.1K | $498 | |
| $9.27M | $9.06M | $8.14M | $6.74M | $5.52M | $3.35M | |
| — | — | — | $3036 | $105.17K | $39.43K | |
| $810.25K | $903.78K | $157.19K | $192.11K | -$105.17K | — | |
| -$7.69M | -$7.59M | -$7.77M | -$6.66M | -$5.68M | -$3.24M | |
| — | -285.2% | -474.6% | -578.18% | -861.16% | -469.76% | |
| USD/shares | — | -$1.90 | -$5.19 | -$10.87 | -$17.40 | — |
| USD/shares | — | -$1.90 | -$5.19 | -$10.87 | -$17.40 | — |
| shares | — | 3.99M | 1.5M | 613K | — | — |
| shares | — | 3.99M | 1.5M | 613K | 326.45K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.62×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 11 similar-size Medical Instruments & Supplies companies (of 48 listed).
Key facts
CIK
1808377
CUSIP
45791D208
13F (30d)
14 filings
14 filers
Visit website
Investor relations